| Literature DB >> 35776437 |
Marscha Engelen1, Betsie van Gaal1,2, Hester Vermeulen1,2, Rixt Zuidema3, Sebastian Bredie4, Sandra van Dulmen5,6,7.
Abstract
BACKGROUND: Self-management can increase self-efficacy and quality of life and improve disease outcomes. Effective self-management may also help reduce the pressure on health care systems. However, patients need support in dealing with their disease and in developing skills to manage the consequences and changes associated with their condition. Web-based self-management support programs have helped patients with cardiovascular disease (CVD) and rheumatoid arthritis (RA), but program use has been low.Entities:
Keywords: cardiovascular diseases; chronic disease; patient dropouts; program use; realistic evaluation; rheumatoid arthritis; self-management; telemedicine
Year: 2022 PMID: 35776437 PMCID: PMC9288100 DOI: 10.2196/34925
Source DB: PubMed Journal: JMIR Hum Factors ISSN: 2292-9495
Figure 1Realistic evaluation: context, potential mechanisms, and outcome. PAM: Patient Activation Measure; PEPPI-5: 5-item version perceived efficacy in patient-physician interactions; RAND-36: RAND 36-item health survey.
Overview of applied determinants and behavior change techniques per program.
| Determinant | Behavior change techniques | Vascular View | Coping with RAa |
| Knowledge | Provide general information about health behavior | ✓b | ✓ |
| Knowledge | Increase memory and/or understanding of transferred information | ✓ | ✓ |
| Awareness | Risk communication | ✓ | ✓ |
| Awareness | Self-monitoring of behavior | ✓ | ✓ |
| Awareness | Self-report of behavior | N/Ac | ✓ |
| Awareness | Delayed feedback of behavior | ✓ | N/A |
| Social influence | Provide information about peer behavior | ✓ | ✓ |
| Social influence | Mobilize social norm | ✓ | N/A |
| Attitude | Re-evaluation of outcomes and self-evaluation | ✓ | N/A |
| Attitude | Persuasive communication | ✓ | ✓ |
| Attitude | Reward behavioral progress | N/A | ✓ |
| Self-efficacy | Modeling | ✓ | ✓ |
| Self-efficacy | Practice and guided practice | ✓ | ✓ |
| Self-efficacy | Plan coping response | N/A | ✓ |
| Self-efficacy | Graded tasks and goal setting | ✓ | N/A |
| Self-efficacy | Reattribution training and external attribution of failure | ✓ | N/A |
| Intention of behavior | General intention formation | ✓ | N/A |
| Intention of behavior | Develop medication schedule | N/A | ✓ |
| Intention of behavior | Specific goal setting | ✓ | N/A |
| Intention of behavior | Review of general and/or specific goals | ✓ | N/A |
| Intention of behavior | Use of social support | N/A | ✓ |
| Action control | Use of cues | N/A | ✓ |
| Action control | Self-persuasion | N/A | ✓ |
| Maintenance | Goals for maintenance | ✓ | N/A |
aRA: rheumatoid arthritis.
b✓: The behavior change technique was included in the program.
cN/A: not applicable.
Figure 2Overview of patient and disease characteristics (context) and program characteristics (potential mechanisms) that influence program use (outcome). Underlined variables are factors associated with program use; italicized variables are factors associated with program use in the interaction effect with diagnosis; and the font size reflects the degree of prediction; *P<.20; **P<.05.
Characteristics of the users and nonusers in the total group, cardiovascular disease (CVD) group, and rheumatoid arthritis (RA) group.
| Characteristics | Total group | CVD group | RA group | |
|
| ||||
|
| Male | 59 (59.6) | 42 (58.3) | 17 (63.0) |
|
| Female | 52 (65) | 21 (72.4) | 31 (60.8) |
|
| ||||
|
| Low | 21 (77.8) | 14 (82.4) | 7 (70.0) |
|
| Intermediate | 40 (51.9) | 16 (47.1) | 24 (55.8) |
|
| High | 50 (66.7) | 33 (66.0) | 17 (68) |
|
| ||||
|
| Yes | 51 (66.2) | 24 (60.0) | 27 (73.0) |
|
| No | 60 (58.8) | 39 (63.9) | 21 (51.2) |
|
| ||||
|
| Alone | 19 (61.3) | 10 (62.5) | 9 (60.0) |
|
| Together | 92 (62.2) | 53 (62.4) | 39 (61.9) |
|
| ||||
|
| Yes | 50 (61.0) | 24 (60.0) | 26 (61.9) |
|
| No | 61 (62.9) | 39 (63.9) | 22 (61.1) |
|
| ||||
|
| Nonusers | 64.5 (10.0)a | 65.1 (9.7)b | 63.8 (10.5)c |
|
| Users | 60.5 (10.4)d | 61.5 (9.4)e | 59.2 (11.6)f |
|
| ||||
|
| Nonusers | 8.7 (10.6)g | 5.0 (7.9)h | 13.4 (11.9)c |
|
| Users | 8.1 (10.6)d | 3.8 (7.7)e | 13.8 (11.2)f |
|
| ||||
|
| Nonusers | 40.2 (4.8)j | 40.7 (4.4)b | 39.5 (5.4)k |
|
| Users | 40.4 (5.5)l | 40.4 (5.5)e | 40.3 (5.6)m |
|
| ||||
|
| Nonusers | 21.4 (3.3)j | 21.3 (2.8)b | 21.5 (3.8)k |
|
| Users | 20.5 (3.3)d | 20.0 (3.6)e | 21.1 (2.9)f |
|
| ||||
|
| Nonusers | 64.0 (27.8)a | 71.3 (25.3)b | 54.3 (28.3)c |
|
| Users | 68.8 (25.1)d | 70.9 (26.0)p | 66.1 (23.9)f |
|
| ||||
|
| Nonusers | 71.9 (24.1)a | 77.6 (22.2)b | 64.6 (24.8)k |
|
| Users | 74.9 (22.4)d | 74.4 (26.0)p | 75.5 (16.7)f |
|
| ||||
|
| Nonusers | 51.1 (43.9)a | 62.5 (41.0)b | 36.7 (43.9)k |
|
| Users | 56.8 (41.1)d | 56.7 (41.2)e | 56.8 (41.5)f |
|
| ||||
|
| Nonusers | 75.1 (40.3)a | 75.4 (40.0)b | 74.7 (41.5)c |
|
| Users | 80.8 (34.1)d | 78.8 (35.1)e | 83.3 (33.0)f |
|
| ||||
|
| Nonusers | 75.5 (17.0)a | 78.1 (17.4)b | 72.1 (16.1)k |
|
| Users | 76.4 (13.9)d | 75.7 (15.4)e | 77.4 (11.7)f |
|
| ||||
|
| Nonusers | 58.4 (21.2)a | 62.5 (19.2)b | 53.1 (22.9)k |
|
| Users | 57.5 (18.9)d | 56.1 (20.4)e | 59.3 (16.9)f |
|
| ||||
|
| Nonusers | 70.0 (26.9)a | 80.2 (23.5)b | 56.9 (25.5)k |
|
| Users | 72.6 (21.8)d | 75.4 (23.5)e | 68.9 (19.0)f |
|
| ||||
|
| Nonusers | 51.3 (19.1)a | 55.4 (18.1)b | 46.0 (19.4)c |
|
| Users | 53.5 (19.0)d | 53.3 (19.9)e | 53.8 (17.8)f |
|
| ||||
|
| Nonusers | 47.8 (22.3)a | 51.3 (23.2)b | 43.3 (20.7)k |
|
| Users | 51.6 (24.8)d | 52.4 (25.3)e | 50.5 (24.5)f |
an=67.
bn=38.
cn=29.
dn=111.
en=63.
fn=48.
gn=66.
hn=37.
iPAM-13: Patient Activation Measure.
jn=68.
kn=30.
ln=110.
mn=47.
nPEPPI-5: 5-item perceived efficacy in patient-physician interactions.
oRAND-36: RAND 36-item health survey.
pn=63.
Results of the univariate logistic regressions for all possible factors for total group.
|
| ORa (95% CI) | |
| Sex | 0.79 (0.43-1.46) | .46 |
| Age | 0.96 (0.93-0.99) | .02b |
| Education (reference: low)—intermediate | 0.31 (0.11-0.85) | .02b |
| Education (reference: low)—high | 0.57 (0.21-1.60) | .29 |
| Employment status | 1.37 (0.74-2.54) | .31 |
| Living situation | 1.04 (0.47-2.30) | .93 |
| Diagnosis | 0.97 (0.53-1.77) | .97 |
| Physical comorbidity | 0.92 (0.50-1.69) | .79 |
| Time since diagnosis | 1.00 (0.97-1.02) | .72 |
| Self-management (PAMc) | 1.01 (0.95-1.07) | .77 |
| Communication efficacy (PEPPId) | 0.92 (0.83-1.01) | .08e |
| Physical functioning (RAND-36f) | 1.01 (1.00-1.02) | .23 |
| Social functioning (RAND-36) | 1.01 (0.99-1.02) | .40 |
| Role physical (RAND-36) | 1.00 (1.00-1.01) | .38 |
| Role emotional (RAND-36) | 1.00 (1.00-1.01) | .32 |
| Mental health (RAND-36) | 1.00 (0.98-1.02) | .68 |
| Vitality (RAND-36) | 1.00 (0.98-1.01) | .78 |
| Bodily pain (RAND-36) | 1.01 (0.99-1.02) | .47 |
| General health (RAND-36) | 1.01 (0.99-1.02) | .47 |
| Health change (RAND-36) | 1.01 (0.99-1.02) | .30 |
aOR: odds ratio.
bP<.05.
cPAM: Patient Activation Measure.
dPEPPI-5: 5-item perceived efficacy in patient-physician interactions.
eP<.20.
fRAND-36: RAND 36-item health survey.
Final model of factors associated with the use of web-based self-management programsa.
|
| B | SE | ORb (95% CI) | |
| Constant | 3.58 | 1.16 | N/Ac | .002 |
| Age | −0.04 | 0.017 | 0.96 (0.93-1.00) | .03 |
| Education (intermediate vs low) | −1.06 | 0.52 | 0.35 (0.12-0.96) | .04 |
aNagelkerke R2=0.049.
bOR: odds ratio.
cN/A: not applicable.
Results of the interaction effects between diagnosis (cardiovascular disease and rheumatoid arthritis) and possible factors.
|
| ORa (95% CI) | |
| Sex | 2.06 (0.54-7.89) | .29 |
| Age | 1.00 (0.94-1.07) | .95 |
| Education (reference: low)—intermediate | 2.84 (0.37-22.06) | .32 |
| Education (reference: low)—high | 2.19 (0.27-17.98) | .47 |
| Employment status | 3.04 (0.87-10.66) | .08b |
| Living situation | 1.09 (0.22-5.37) | .92 |
| Physical comorbidity | 1.22 (0.36-4.18) | .75 |
| Time since diagnosis | 1.02 (0.96-1.09) | .50 |
| Self-management (PAMc) | 1.04 (0.93-1.17) | .52 |
| Communication efficacy (PEPPId) | 1.09 (0.90-1.33) | .39 |
| Physical functioning (RAND-36e) | 1.02 (0.99-1.04) | .14b |
| Social functioning (RAND-36) | 1.03 (1.00-1.06) | .03f |
| Role physical (RAND-36) | 1.02 (1.00-1.03) | .05f |
| Role emotional (RAND-36) | 1.00 (0.99-1.02) | .64 |
| Mental health (RAND-36) | 1.04 (1.00-1.08) | .08b |
| Vitality (RAND-36) | 1.03 (1.00-1.07) | .04f |
| Bodily pain (RAND-36) | 1.04 (1.01-1.06) | .02f |
| General health (RAND-36) | 1.03 (1.00-1.07) | .09b |
| Health change (RAND-36) | 1.01 (0.99-1.04) | .37 |
aOR: odds ratio.
bP<.20.
cPAM: Patient Activation Measure.
dPEPPI: Perceived Efficacy in Patient-Physician Interactions.
eRAND-36: RAND 36-item health survey.
fP<.05.
Quotes from the interviews with users and nonusers.
|
| Barriers | Facilitators |
| Program design | “Well, I couldn’t log in. Somehow I really couldn’t, or it wasn’t clear to me. Through the internet I find it very difficult to do.” (Coping with RAa, participant 5) |
“Yes I liked the lay-out. The information was orderly, you could easily click on what you wanted to see. So the program was very well organized.” (Coping with RA, participant 21) |
| Implementation strategies | Barriers for implementation were not described. |
“The hospital nurse advised me to use the program.” (Vascular View, participant 1) “If I received an email that said I still had something to do, I always did.” (Coping with RA, participant 8) |
| Behavior change techniques | “The program only gives input but I missed feedback options, for example to keep track of my weight.” (Vascular View, participant 16) |
“I wanted information on how to deal with my recent diagnosis.” (Vascular View, participant 7) |
aRA: rheumatoid arthritis.